Ceo
CurrentCELL2BIO developing a novel platform for 3D Sphere Cell-growth. Our platform can be used in drug discovery to enable personalized medicine.
Please complete the CAPTCHA to continue
@stalemark.se
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Jan Stålemark is listed as CEO at Cell2Bio AB, based in Stockholm, Stockholm County, Sweden. AeroLeads shows a work email signal at stalemark.se and a matched LinkedIn profile for Jan Stålemark.
Jan Stålemark previously worked as CEO at Healthtech Sweden Ab and Interim Chief Executive Officer at Nectarine Health Ab. Jan Stålemark studied at Miscellaneous.
This section adds company-level context without repeating Jan Stålemark's masked contact details.
AeroLeads found 1 current-domain work email signal for Jan Stålemark. Compare company email patterns before reaching out.
Senior level executive with strong ethical principles. Skilled in Sales, Marketing and Customer Relations with world wide business experience. In addition to Sales & Marketing experience Jan has a strong technical and biomedical engineering background. Jan believe in customer excellence and satisfaction and partnering with customers to achieve great results.He is passionate about his business and the people he work with. His goal is to build winning teams based on these principles and create a sustainable and profitable business for the shareholders.Specialties: Entreprenural Company Management, Early Stage, Startup to +500 Companies.Global Sales Channel Management - Distributors & Direct Sales via subsidiary - Healthcare Economics & Reimbursement
Listed skills include Medical Devices, Capital Equipment, New Business Development, Cardiology, and 27 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
CELL2BIO developing a novel platform for 3D Sphere Cell-growth. Our platform can be used in drug discovery to enable personalized medicine.
Interim Management Services and general consulting services within all areas of companies in the Life Science industry
Brighter was launched in 2007 to develop a method that facilitates self-monitoring and self-treatment of diabetes. Brighter’s basic patent for this method triggered product development, which in turn, led to a broader platform. From its launch, Brighter’s patent portfolio extended beyond diabetes—to address future, medication-driven needs based on treatments that cannot be taken orally and must be injected. Brighter’s business model includes out-licensed rights to its platform.
AroCell AB was founded in 2003. The company is located in Uppsala, Sweden and develops and commercializes tests that can be used in the prognosis, monitoring and follow-up of cancer.Successfully raised a total of 118 MSEK and developed a world class immunoassay for a novel biomarker. Signed global licensing agreement with market leader Roche. Listed the company at Nasdaq First North in 2016. Market CAP growth 300%.The AroCell share (AROC) is listed on Nasdaq First North.
Solna, Stockholm County, Se
ObsteCare AB is a provider of medical solutions with a global focus on improving delivery care for both the mother and the healthcare provider. This is done by supplying reliable services and products, facilitating efficient care in maternity wards.The company was founded on ground-breaking research at the Karolinska Institute, based upon the effect of lactate in the amniotic fluid of delivering mothers. The products originating from the research are the result of more than 20 years of in-depth knowledge of the practical situation in delivery wards. With focus on cutting-edge technology, ObsteCare provides innovative solutions helping to improve quality of care during the delivery process. The product line is built on a patented¹ technology and is the only solution available on the market for Point-of-Care use in monitoring lactate in amniotic fluid.
Gothenburg, Se
Global Marketing responsibility for all of Maquet Critical Care's products.
Medical Device Company Neoventa is a Swedish medical device company founded in 1997. We are a provider of fetal monitoring solutions and services that improve obstetric care. Every day, across the globe in over 500 obstetric centers, our unique solutions are used by health care professionals to ensure a good start in life.We are one of the few companies world wide that can offer a complete line of products and services for obstetric care covering hardware platforms, software solutions, consumables, accessories, education and services.Our core competence lies within the evidenced based Stan method that combines cardiotocography with monitoring of the fetal ECG during childbirth and the state-of-art fetal scalp electrode – Goldtrace. Neoventa is maintaining a quality system which meets the requirements of MDD 93/42/EEC, ISO 13485:2003 and FDA regulations.Our head office is located in Gothenburg, Sweden, with subsidiaries in Boston, USA and Paris, France.We go to market with our solutions and services by either direct sales or through a strong worldwide distributor network.Neoventa is owned by Investor Growth Capital, CapMan Life Science and SEB Venture Capital.
Mölndal, Se
Neoventa is a Swedish medical device company founded in 1997. We are a provider of fetal monitoring solutions and services that improve obstetric care. Every day, across the globe in over 500 obstetric centers, our unique solutions are used by health care professionals to ensure a good start in life.We are one of the few companies world wide that can offer a complete line of products and services for obstetric care covering hardware platforms, software solutions, consumables, accessories, education and services.Our core competence lies within the evidenced based Stan method that combines cardiotocography with monitoring of the fetal ECG during childbirth and the state-of-art fetal scalp electrode – Goldtrace. Neoventa is maintaining a quality system which meets the requirements of MDD 93/42/EEC, ISO 13485:2003 and FDA regulations.Our head office is located in Gothenburg, Sweden, with subsidiaries in Boston, USA and Paris, France.We go to market with our solutions and services by either direct sales or through a strong worldwide distributor network.Neoventa is owned by Investor Growth Capital, CapMan Life Science and SEB Venture Capital.
New Brunswick, Nj, Us
For more than two decades, LifeScan, Inc. has been committed to improving the quality of life for people with diabetes. At LifeScan, we truly believe that caring makes the difference. By offering you this online experience, we hope we have given you just one more reason to believe in our commitment to diabetes care. And our commitment to you. Over the years, our OneTouch® Systems have become a brand recommended by doctors, pharmacists and diabetes educators. Every day, more than three million people depend on our products for simple testing and accurate results. A Johnson & Johnson Company since November 1986, LifeScan is headquartered in Milpitas, California. We also have manufacturing facilities in Puerto Rico and Scotland, and employ more than 2500 employees worldwide.ProductsLifeScan pioneered the modern era of blood glucose monitoring with the introduction of OneTouch® Technology, which eliminated wiping and timing procedures. The OneTouch Brand offers everything you need to test: blood glucose meters, test strips, lancing devices and diabetes management software. Our products are accurate, convenient and can help make testing less painful.*
Se
VP Marketing & Sales 2000-2001VP Marketing 2001-2003During Excecutive MBA program. VP Remibursment 2003-2004
Global responsibilty for existing and future generation plattforms, hardware och software, for Cardiac Hemodynamic CathLabs. The annual revenue was €35M with a growthrate of 25%.
Quality assurance and complaint management at Siemens Life Support Systems. Taking part in several business process re-engineering projects, Intense FDA inspections.
Responsible for a team of 18: 1 Procurement Officer, 3 Group Leaders and 14 Biomedical Engineers. The department provided technical repair and preventive maintenance, product training and education in handling medical equipment safely. In addition to all the clinics at the hospital the department also provided the same services to the primary care in stocholm city center and the western suburbs. This also included the local diagnostic clinical lab's and the homecare.
Consulting services toward healthcare providers and the medical devices industry. Safety inspections of device installations, Education and training in handling medical devices safely, Incident Investigations of adverse events, Incident monitoring and reporting back to healthcare providers and industry.
Service management, Hospital Turn Key projects and handover to the Ministry of Health.
Quick answers generated from the profile data available on this page.
Jan Stålemark works for Cell2Bio AB.
Jan Stålemark is listed as CEO at Cell2Bio AB.
AeroLeads has found 1 work email signal at @stalemark.se for Jan Stålemark at Cell2Bio AB.
Jan Stålemark is based in Stockholm, Stockholm County, Sweden while working with Cell2Bio AB.
Jan Stålemark has worked for Cell2Bio Ab, Healthtech Sweden Ab, Nectarine Health Ab, Brighter Ab (Publ), and Arocell Ab.
You can use AeroLeads to view verified contact signals for Jan Stålemark at Cell2Bio AB, including work email, phone, and LinkedIn data when available.
Jan Stålemark studied at Miscellaneous.
Jan Stålemark is listed with skills including Medical Devices, Capital Equipment, New Business Development, Cardiology, Global Marketing, Market Development, Product Launch, and Commercialization.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts